SynthesisEuropean journal of clinical pharmacology2025

Grade ≥ 3 hematologic adverse events of immunotherapy in advanced NSCLC patients: a systematic review and meta-analysis.

Shuang Wang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.